Meanwhile, St. Joseph Medical Center’s corporate responsibility officer Linda Pilla has also announced her resignation. Their announcements come amid a leadership shake-up at the hospital. Charles Neumann was named the successor to former CEO Jeffrey Norman, whose tenure expired last week.
Mr. Norman was appointed CEO in the middle of another management shake-up in 2009 after Mark Midei, MD, a cardiologist at the hospital, left amid allegations he had performed numerous unnecessary stent procedures.
Related Articles on St. Joseph Medical Center:
St. Joseph Medical Center in Maryland Names Charles W. Neumann CEO
CEO Jeffrey K. Norman of St. Joseph Medical Center in Maryland Resigns Amid Stent Controversy
Former Cardiologist From Maryland’s St. Joseph Medical Center Loses Medical License Over Unnecessary Stent Allegations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
